Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women
Completed · Not applicable · Has a placebo group
Conditions studied: Pregnancy, Smoking
In brief
Women who smoke during their pregnancy place their unborn child at an increased risk of health problems, including decreased lung function and possible lung diseases later in life. Preliminary animal research suggests that if vitamin C is taken during pregnancy, nicotine's harmful effects on the unborn baby's developing lungs may be blocked. This study will determine the effect that vitamin C has on the lung development and function of babies born to women who smoke during pregnancy.
Key facts
- Study ID
- NCT00632476
- Run by
- Oregon Health and Science University
- People needed
- 282
- Starts
- 2007-03-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2013-09-04
Who can join
Age: 15 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Randomly assigned to a study intervention at less than 22 weeks of gestation
- History of smoking
- Singleton gestation pregnancy
- Smoking cessation intervention offered but declined
You may not qualify if…
- Multiple gestation pregnancy
- Documented major fetal congenital anomalies
- History of kidney stones
- Insulin dependent diabetes
- Current participation in other research projects that may interfere with this study
- Continuous use of high dose vitamin C since last menstrual period (LMP) or initial ascorbic acid level greater than 100 micromoles/liter
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.